Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$426.8M
+8.2% from 2023
Prescriptions
26K
$16,162.84 per claim
Patients
3,052
3,140 prescribers
Total spending, 2024
$427.0M
$139,804.11 per patient
Medicare prescription drug plans paid $426.8M for Tasigna in 2024, for 26,408 prescriptions and refills to 3,052 patients (up 8.2% from 2023). The average cost per claim was $16,162.84.
California had the highest Medicare cost for Tasigna in 2024: $45.4M for 2,870 claims, followed by Florida ($32.2M).
Lori J Maness-Harris, hematology in Omaha, NE, had the highest Medicare cost for Tasigna in 2024: 106 claims costing $1.3M.
Tasigna is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Lori J Maness-Harris Omaha, NE | Hematology | 106 | Under 11 | $1.3M |
| Wahid T Hanna Knoxville, TN | Hematology-Oncology | 96 | Under 11 | $1.3M |
| Michael J Moffett |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 3,076 | 25,744 | 3,022 | $375.9M |
| 2023 | 3,075 | 24,542 | 2,960 | $394.6M |
| 2024 | 3,140 | 26,408 | 3,052 | $426.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 57 |
| Under 11 |
| $1.2M |
| Michael P Carroll Sacramento, CA | Hematology-Oncology | 47 | Under 11 | $972K |
| Paul M Brager Bridgport, WV | Hematology-Oncology | 47 | Under 11 | $960K |
| Varant B Arzoumanian Fort Smith, AR | Hematology-Oncology | 49 | Under 11 | $941K |
| Kee Y Shum Flushing, NY | Internal Medicine | 46 | Under 11 | $920K |
| Samir Alsawah Port Huron, MI | Hematology-Oncology | 50 | Under 11 | $876K |
| David M Spector Moline, IL | Medical Oncology | 53 | Under 11 | $849K |
| Syed F Hassany Muskogee, OK | Hematology-Oncology | 44 | Under 11 | $825K |
| Hector A Velez Cortes Ponce, PR | Hematology-Oncology | 45 | Under 11 | $747K |
| Doron Weiner Rockville Centre, NY | Hematology-Oncology | 39 | Under 11 | $736K |
| Shakir Sarwar Westerville, OH | Hematology-Oncology | 36 | Under 11 | $729K |
| Samuel D Bailey Hazard, KY | Hematology-Oncology | 38 | Under 11 | $720K |
| Narender R Jogenpally South Charleston, WV | Hematology-Oncology | 40 | Under 11 | $706K |
| Elizabeth H Cull Greenville, SC | Hematology-Oncology | 52 | Under 11 | $702K |
| Sang Hoon AHN Fullerton, CA | Hematology-Oncology | 40 | Under 11 | $701K |
| Manuel F Gonzalez Sumter, SC | Hematology-Oncology | 35 | Under 11 | $700K |
| James E Carinder Covington, LA | Hematology-Oncology | 35 | Under 11 | $689K |
| Aleda A Toma Oklahoma City, OK | Hematology-Oncology | 42 | Under 11 | $666K |
| Kathleen Mitchell Lawrence, MA | Nurse Practitioner | 35 | Under 11 | $662K |
| Jeffrey T Yorio Austin, TX | Hematology-Oncology | 35 | Under 11 | $660K |
| James O Brady Wilkes Barre, PA | Hematology-Oncology | 36 | Under 11 | $655K |
| Jorge G Otoya Kissimmee, FL | Medical Oncology | 32 | Under 11 | $643K |
| Joseph R Jones Daphne, AL | Hematology-Oncology | 35 | Under 11 | $636K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 26,420 | $427.0M |